Moderna (MRNA) Debt/EBITDA US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 6.60 | -1.25 | -0.90 | -0.89 | 2.29 | 1.80 | |||
Changes by years, y/y, % | +219% | -119% | -28% | -1% | -357% | -10.6% |
Moderna. Debt/EBITDA
Moderna. Debt/EBITDA, changes, %
Moderna (MRNA) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
Debt/EBITDA | 0.67 | 2.81 | 2.09 | 1.63 | 1.80 | 1.80 | ||
Changes by years, y/y, % | -228% | -638% | -332% | -204% | -121% | |||
Changes by quarters, q/q, % | -108% | +322% | -26% | -22% | +10% |